Merck, a leading science and technology company, has launched the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable ...
Merck and Eisai provide update on phase 3 LITESPARK-012 trial evaluating first-line combination treatments for certain patients with advanced RCC: Rahway, New Jersey Wednesday, Ap ...
Integrated DNA Technologies expands Coralville manufacturing footprint to support global demand for minimal residual disease solutions: Coralville, Iowa Wednesday, April 22, 2026, ...
Dana-Farber Cancer Institute’s study shows predictive value of Ignite Proteomics’ RPPA platform for Enhertu therapy in metastatic breast cancer: Mountain View, California Wedn ...
Jaslok Hospital launches clinical study to enable AI-based prediction of Parkinson’s freezing episodes: Our Bureau, Mumbai ...
HCL Healthcare deepens Bengaluru presence with Central Regional Office, enhances accessibility for enterprise clients: Our Bureau, Bengaluru Wednesday, April 22, 2026, 11:30 Hrs [ ...
US FDA accepts Roche’s sBLA for Gazyva/Gazyvaro for the treatment of systemic lupus erythematosus: Basel Wednesday, April 22, 2026, 09:00 Hrs [IST] Roche announced that the US F ...
Positive high-level results from a prespecified interim analysis of the I CAN phase III trial showed that Ultomiris (ravulizumab) met its primary endpoint, demonstrating a statistically significant ...
The Union ministry of health and family welfare has amended the recruitment rules for appointment of Drugs Controller General of India (DCGI) by deputation including short-term contract (ISTC) with ...
Indian healthcare sector faces escalating cyber risks as complex hospital IT systems widen attack surface: Nandita Vijayasimha, Bengaluru Wednesday, April 22, 2026, 08:00 Hrs [IST ...
MedTech startup MediElaj aims expansion of AI-based healthcare model: Our Bureau, New Delhi Wednesday, April 22, 2026, 08:00 Hrs [IST] MedTech startup MediElaj is planning to roll ...
The new recommendation by the DTAB is in deviation from the earlier proposal that the qualification of the competent person should be with pharmacy background only i.e. D. Pharmacy/B. Pharmacy/M.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results